Spyre Therapeutics, Inc. is in its Ketu mahadasha (18 Mar 2022 to 18 Mar 2029), Jupiter antardasha (6 Mar 2026 to 10 Feb 2027) and Sun pratyantar (16 Oct 2026 to 2 Nov 2026).
Next: pratyantar Moon from 2 Nov 2026; antardasha Saturn from 10 Feb 2027; mahadasha Venus from 18 Mar 2029.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Meena (Pisces) | 24°05′ | 11th | Revati 3 |
| Moon | Meena (Pisces) | 25°20′ | 11th | Revati 3 |
| Mars | Vrishchika (Scorpio) | 14°15′ | 7th | Anuradha 4 |
| Mercury | Mesha (Aries) | 8°53′ | 12th | Ashwini 3 |
| Jupiter (R) | Simha (Leo) | 20°42′ | 4th | Purva Phalguni 3 |
| Venus | Meena (Pisces) | 8°14′ | 11th | Uttara Bhadrapada 2 |
| Saturn (R) | Vrishchika (Scorpio) | 22°11′ | 7th | Jyeshtha 2 |
| Rahu | Simha (Leo) | 26°22′ | 4th | Purva Phalguni 4 |
| Ketu | Kumbha (Aquarius) | 26°22′ | 10th | Purva Bhadrapada 2 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how SYRE moved in each period against the S&P 500, transits, fundamentals and news.